diabetes
With the achievement of this new milestone, both companies will now advance this research which focuses on developing innovative therapies for metabolic diseases.
The findings of a new research suggest that combining Lachnospiraceae antibody screening with blood tests could improve the diagnosis of ME/CFS.
The findings of a new study suggest that the interplay between diet, microbiota and intestinal immunity regulates obesity, diabetes and other metabolic conditions.
The findings of a recent study suggest that engineered native gut bacteria could be employed to help treat certain diseases such as diabetes.
Some gut and mouth bacteria produce enzymes that metabolize acarbose, a common antidiabetic drug, in ways that may reduce its therapeutic efficacy. A new study published in Nature claims.
A new study published in Cell Host & Microbe suggests that the transfer of gut microbes from a mother to her offsprin could reduce the risk of developing type 1…
A new study suggests that 24-hour changes in the gut microbiota could help to predict who’s at risk of developing type 2 diabetes.
Gut microbiota could make the anti-diabetic drug metformin less effective, researchers from the University of Gothenburg have found.
Researchers have found that alterations in the gut microbiota composition in prediabetic people could contribute to type 2 diabetes.
A study in mice suggests that short-term intermittent fasting alters the gut microbiota, alleviating the cognitive deficits associated with diabetes.
